Product Information
BUPRENORPHINE 15 MCG/HR PATCH is a generic product labeled by Alvogen Inc., priced at $50.1598 per EA under NDC 47781041904. Its NADAC has been published 195 times since Nov 9, 2022.
FDA first approved this application on May 17, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 ug/h
Manufacturer
Alvogen Inc.NDC
47781041904
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
7/22/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA207490FDA Approved
5/17/2022
TE Code
AB
On Market Since
5/17/2022
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 15 MCG/HR PATCH has been published 195 times since Nov 9, 2022, and over the history we have for it it has declined 31.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $50.1598 per EA |
|---|---|
| All-time high | $95.2203 (Sep 13, 2023) |
| All-time low | $33.1572 (Jul 17, 2024) |
| 52-week high | $50.7876 |
| 52-week low | $44.1510 |
| Median price | $53.5498 |
| Average price | $56.4800 |
| Largest weekly change | +62.3% (Aug 21, 2024) |
| Weeks tracked | 195 |
| Tracking since | Nov 9, 2022 |
1W
N/A
1M
0.0%
3M
+11.8%
6M
+0.7%
1Y
-1.2%
3Y
-30.8%
5Y
N/A
All
-31.7%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 15 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 15 MCG/HR PATCH, manufactured by Alvogen Inc., is $50.1598 per EA (NDC 47781041904), effective Jul 29, 2026.
How has the price of BUPRENORPHINE 15 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 15 MCG/HR PATCH has declined 31.7%. It has been tracked across 195 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 15 MCG/HR PATCH?
Since Nov 9, 2022, the NADAC for BUPRENORPHINE 15 MCG/HR PATCH has ranged from a low of $33.1572 (Jul 17, 2024) to a high of $95.2203 (Sep 13, 2023), with a median of $53.5498 per EA.
Are there cheaper alternatives to BUPRENORPHINE 15 MCG/HR PATCH?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 15 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 15 MCG/HR PATCH?
BUPRENORPHINE 15 MCG/HR PATCH (NDC 47781041904) is labeled by Alvogen Inc., and CMS classifies it as a generic product.